Hanson McClain Advisors »

Tango Therapeutics shares owned by Hanson McClain Advisors

Quarter-by-quarter ownership of Tango Therapeutics (TNGX) shares owned by Hanson McClain Advisors from 13F filings

Historical chart of Hanson McClain Advisors investment in Tango Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Tango Therapeutics held by Hanson McClain Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Tango Therapeutics by Hanson McClain Advisors

Quarter filed Position value Share count Share price at filing
2025-09-30 $320 38 8.42
2025-06-30 $180 35 5.14
2024-12-31 $1.5k 474 3.08

More positions owned by Hanson McClain Advisors

Vanguard Index Fds Total Stk Mkt (VTI)
Vanguard Bd Index Fds Total Bnd Mrkt (BND)
Vanguard Bd Index Fds Short Trm Bond (BSV)
Spdr Index Shs Fds Portfolio Devlpd (SPDW)
Spdr Series Trust Prtflo S&p500 Gw (SPYG)
Spdr Series Trust Prtflo S&p500 Vl (SPYV)
Ishares Tr Us Treas Bd Etf (GOVT)
Apple Call Call Option (Principal) (AAPL)
Spdr Index Shs Fds Portfolio Emg Mk (SPEM)
Vanguard Index Fds Mid Cap Etf (VO)
Ishares Tr Mbs Etf (MBB)
2023 Etf Series Trust Ii Gmo Us Quality E (QLTY)
Ishares Tr Core S&p Ttl Stk (ITOT)
Ishares Tr Usd Inv Grde Etf (USIG)
Nvidia Corporation Call Call Option (Principal) (NVDA)

View all positions for Hanson McClain Advisors

Top funds holding Tango Therapeutics

Trv Gp Iv
Farallon Capital Management
EcoR1 Capital
Boxer Capital Management
TCG Crossover Management
Woodline Partners
Siren
BlackRock
Nextech Invest
Vanguard Group
Gilead Sciences
T. Rowe Price Investment Management
Balyasny Asset Management
State Street Corporation
Paradigm Biocapital Advisors

View all funds holding Tango Therapeutics